Core capability across PULSE (nano-imprint lithography), ODYSSEY (nano-fabrication for lenses), and BIOMAC (nanomaterials processing).
NANOTYPOS EE
Greek SME providing nano-imprint lithography and nano-fabrication for optics, laser manufacturing, and biomedical nanostructures.
Their core work
Nanotypos is a Greek SME specializing in nano-fabrication and nano-imprint lithography, providing precision nanoscale patterning capabilities for industrial and biomedical applications. They bring nano-optics and laser-based manufacturing expertise to EU consortia, enabling partners to produce micro- and nano-structured surfaces for optics, automotive components, and biomedical implants. Their work spans from on-demand laser-printed prescription lenses to nanoparticle-based materials for in-vivo imaging and bioengineered implants.
What they specialise in
PULSE focused on ultrafast laser systems and polygon scanning; ODYSSEY applied laser printing for on-demand eyeglass production.
ODYSSEY centered on nano-optics for prescription lenses; PULSE addressed automotive optical applications.
BIOMAC involves biopolymer nanomaterials; IN2SIGHT applies nanoparticles and biocompatibility testing for implant materials.
IN2SIGHT uses 2-photon activated polymerization for in-vivo optical imaging windows.
How they've shifted over time
Nanotypos entered H2020 with a clear industrial photonics focus — ultrafast lasers, polygon scanning, nano-imprint lithography for automotive and optical manufacturing (PULSE, ODYSSEY in 2019-2020). From 2021 onward, their work shifted significantly toward bio-nanomaterials and biomedical applications, joining projects on biopolymer nanomaterials (BIOMAC) and bioengineered implant imaging (IN2SIGHT). This pivot suggests they are applying their core nano-fabrication skills to the life sciences sector, a diversification that broadens their addressable market considerably.
Nanotypos is migrating its nano-fabrication expertise from pure industrial photonics toward biomedical and sustainable materials applications, positioning itself at the intersection of nanotechnology and life sciences.
How they like to work
Nanotypos operates exclusively as a participant, never coordinating — typical of a specialist SME that contributes deep technical capabilities rather than managing large consortia. With 58 unique partners across 15 countries from just 4 projects, they work in large, diverse consortia (averaging ~15 partners per project). This pattern indicates they are sought after as a niche technology provider whose nano-fabrication skills complement broader research efforts.
Despite only 4 projects, Nanotypos has built a wide network of 58 partners across 15 countries, indicating participation in large multi-national consortia. Their reach spans well beyond Greece, with strong European coverage typical of FET and RIA collaborative projects.
What sets them apart
Nanotypos occupies a rare niche as a Greek SME with hands-on nano-imprint lithography and nano-fabrication production capabilities — not just research, but applied manufacturing at the nanoscale. Their ability to bridge industrial photonics (lasers, optics, automotive) and biomedical nanotechnology (implant materials, in-vivo imaging) makes them unusually versatile for an SME of their size. For consortium builders, they offer a practical nano-fabrication partner who can translate lab-scale nanostructures into functional prototypes.
Highlights from their portfolio
- ODYSSEYLargest single grant (EUR 424,688) and a compelling real-world application: laser-printing prescription eyeglasses on demand in retail shops.
- IN2SIGHTRepresents their boldest pivot — applying nano-fabrication to bioengineered in-vivo imaging chips for preclinical validation, far from their industrial roots.
- BIOMACTheir largest long-running project (EUR 339,938), connecting them to the European sustainable bio-nanomaterials community with standardization and open collaboration goals.